EMJ Podcast: Insights For Healthcare Professionals

In the final episode of this series, Professor Habib Naqvi MBE looks ahead to the future of equitable healthcare. From the economic impact of health inequalities and rebuilding trust with underserved communities to the role of patients in shaping healthcare policy, he explores the changes needed to create a fairer NHS. The episode also examines emerging challenges in health equity, lessons from international approaches, and the reasons for optimism about the future of race equity and healthcare.

Timestamps:

· 1:07 – Equity: A Moral and Economic Priority

· 04:06 – The Bigger Picture

· 05:28 – Building Trust

· 07:50 – International Partnerships

· 10:00 – New Trends

· 11:48 – Patients and Communities

· 14:30 – Intersectionality

· 15:59 – Looking Forward

· 17:46 - Optimism

What roles do leadership, workforce equality, and accountability play in achieving health equity? In Part 2, Professor Habib Naqvi MBE explores the link between staff experience and patient outcomes, discusses the realities faced by ethnic minority NHS staff, examines why translating good intentions into meaningful action remains challenging, and explains how data, leadership, and openly addressing racism are essential to driving lasting change across the healthcare system.

Timestamps

· 01:01– Workforce Inequality

· 05:37 – From Policy to Action

· 07:29 – Data Limitations

· 09:53 – The 'Model Organisation'

· 12:34 – Accountability

In this episode of Hema Now, Lucas Kühne explores the evolving landscape of immune thrombotic thrombocytopenic purpura, discussing advances in treatment, the importance of early recognition and accurate diagnosis, the growing role of real-world evidence, and why international collaboration is critical to accelerating research and improving patient care in rare thrombotic microangiopathies.

Timestamps:

00:00 – Introduction

01:40 - Career inspiration and TMA interest

03:11 - Major advances in iTTP treatment

05:05 - Recognising iTTP earlier

07:08 - Distinguishing between TMAs

09:05 - Value of real-world evidence

12:13 - Future priorities in iTTP research

13:32 - Importance of research collaboration

14:57 - Advice for future researchers

15:53 - Future of TMA care

In this episode, Habib Naqvi explores the current state of race and health inequalities in the UK. Marking the fifth anniversary of the NHS Race and Health Observatory, he reflects on how the conversation around health equity has evolved, discusses the persistent disparities affecting ethnic minority communities, examines the role of healthcare systems and wider social determinants, and addresses the misconceptions that continue to hinder progress towards equitable healthcare.

In this rapid-fire episode, Habib Naqvi answers key questions on health equity, race and the future of the NHS. From the most overlooked determinants of health and common misconceptions about health inequalities to leadership, the achievements of the NHS Race and Health Observatory, and the changes needed to create a fairer healthcare system, this episode offers concise insights for anyone interested in improving health outcomes and advancing equity.

This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The content contained in this program was jointly developed by AMJ, the speakers, and Sanofi and Regeneron, and is not eligible for continuing medical education (CME) credits. The speakers were compensated by Sanofi and Regeneron in connection with this program.

COPD trial outcomes are not all equal, yet conventional endpoints can make it difficult to weigh severe events, exacerbations, lung function, and symptom burden within a single clinical picture.

In this AMJ podcast, Sanjay Ramakrishnan and Simon Couillard discuss how win ratio methodology may help capture a broader, more clinically meaningful view of treatment benefit by comparing outcomes across a prespecified hierarchy.

Listen to the full episode to learn:

• Why standard COPD endpoints may not tell the full story
• How win ratio analysis prioritizes outcomes by clinical importance
• What the pooled BOREAS and NOTUS analysis showed
• How this approach could shape future respiratory trial design

Speakers:

• Sanjay Ramakrishnan, Clinical Senior Lecturer, UWA Medical School, Centre for Respiratory Health, The University of Western Australia, Perth, Australia
• Simon Couillard, Professor, Faculty of Medicine and Health, Université de Sherbrooke, Quebec, Canada

In the final episode, Veeru Kasivisvanathan discusses the future of prostate cancer diagnosis, including AI-assisted MRI interpretation, genomic risk prediction, polygenic risk scores, and the opportunities and challenges of population screening. Discover how precision technologies could reshape prostate cancer care over the next decade.

Timestamps:

00:57 – AI and MRI

02:25 – PARADIGM study

02:51 – Large-scale MRI screening

04:56 – Genomics and polygenic risk scores

06:45 – Future optimism of prostate cancer

Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard.

Timestamps:

01:05 – Traditional diagnostic approaches

02:55 – PRECISION trial

05:03 – MRI challenges

Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard.

01:05 – Traditional diagnostic approaches

02:55 – PRECISION trial

05:03 – MRI challenges

In this rapid-fire episode, Veeru Kasivisvanathan answers key questions on prostate cancer diagnosis, MRI, prostate biopsy, overdiagnosis, AI, and future innovations. From common misconceptions to emerging technologies, this concise episode delivers expert insights into one of the fastest-evolving areas of urology.